Bioglutide (NA-931) Dosing Calculator
Pre-filled with the most-reported clinical reconstitution protocol for Bioglutide (NA-931). See how 1 mL and 2 mL of bacteriostatic water change concentration and syringe-draw volume, then adjust the calculator below for your own vial.
Quick answer · Clinical protocol
A 10 mg vial of Bioglutide (NA-931) reconstituted with 2 mL of bacteriostatic water yields a concentration of 5.00 mg/mL. At that concentration, a 150 mg dose of Bioglutide (NA-931) equals 3000 units on a U-100 insulin syringe (30.000 mL). Bioglutide (NA-931) is typically administered once daily.
Bioglutide (NA-931) reconstitution: 1 mL vs 2 mL bac water
Bacteriostatic water volume is flexible. Less water means higher concentration and smaller injection volumes; more water means lower concentration and easier dose precision. Both options below are valid for a 10 mg vial.
| BAC water added | Concentration | Volume per 150 mg dose | Draw on U-100 syringe (units) |
|---|---|---|---|
| 1 mL | 10.00 mg/mL | 15.000 mL | 1500 units |
| 2 mL | 5.00 mg/mL | 30.000 mL | 3000 units |
Calculate your Bioglutide (NA-931) dose
Alternative Bioglutide (NA-931) protocols
Beyond the default above, Bioglutide (NA-931) is also reported in the following protocols. Use these as starting points and recalculate with the tool above.
Phase 2 Weight Loss Trial (NCT06564753)
Clinical- Dose
- Ascending doses up to 150 mg daily in adults with obesity or overweight with comorbidities over 13 weeks. The 150 mg daily dose achieved maximum efficacy.
- Frequency
- Once daily oral capsule
- Duration
- 13 weeks
Phase 2 study in 125 adults. Maximum mean weight loss of 13.8% at 150 mg daily. 72% of treated subjects achieved at least 12% weight loss. No fasting or food restrictions required.
Combination Therapy with Tirzepatide (NCT06732245)
Clinical- Dose
- NA-931 150 mg daily oral capsule combined with tirzepatide subcutaneous injection in adults with obesity or overweight. Designed to evaluate synergistic effects.
- Frequency
- NA-931 once daily oral; tirzepatide once weekly subcutaneous
- Duration
- Under investigation
Phase 2 study enrolling 224 participants. Designed to assess whether combination produces synergistic weight loss while reducing GI adverse events and preserving muscle mass. Preclinical studies showed synergistic effects on weight, glucose, and lipids.
Bioglutide (NA-931) reconstitution & storage
No reconstitution required. Bioglutide (NA-931) is supplied as an oral capsule that is taken by mouth. Unlike injectable GLP-1 receptor agonists, no mixing, dilution, or injection preparation is necessary.
Storage conditions for Bioglutide have not been publicly disclosed in detail. Clinical trial supplies are managed according to sponsor protocols. As a small molecule oral capsule, standard pharmaceutical storage conditions (room temperature, protected from moisture and light) are expected.
Bioglutide (NA-931) dosing FAQ
How much bacteriostatic water should I add to a 10 mg vial of Bioglutide (NA-931)?
The community standard is 2 mL of bacteriostatic water for a 10 mg Bioglutide (NA-931) vial. That gives a concentration of 5.00 mg/mL, so a 150 mg dose is 3000 units on a U-100 insulin syringe. Adding 1 mL instead doubles the concentration to 10.00 mg/mL and halves the draw to 1500 units. Less water = smaller injection volume but harder to measure precisely.
How many syringe units is a 150 mg dose of Bioglutide (NA-931)?
On a standard U-100 insulin syringe, a 150 mg dose of Bioglutide (NA-931) is 3000 units when the 10 mg vial is reconstituted with 2 mL of bacteriostatic water (5.00 mg/mL). If you use 1 mL of bac water instead, draw 1500 units (10.00 mg/mL).
What is the standard Bioglutide (NA-931) dose?
Clinical protocols for Bioglutide (NA-931) typically use 150 mg–28 mg once daily via subcutaneous injection. 150 mg is a common starting dose. Phase 1 study in 74 otherwise healthy overweight/obese adults. Dose-dependent weight loss up to 6.4% at Day 28. Weight loss maintained or improved at Day 35 (7 days post-last dose).
Where do you inject Bioglutide (NA-931)?
Bioglutide (NA-931) is typically administered subcutaneously. Common subcutaneous sites are the lower abdomen (at least an inch from the navel), the outer thigh, and the love handles. Rotate sites with each injection to reduce localized irritation and bruising.
Can I use sterile water instead of bacteriostatic water for Bioglutide (NA-931)?
Bacteriostatic water (containing 0.9% benzyl alcohol as a preservative) is strongly preferred for multi-dose vials like Bioglutide (NA-931) because it inhibits microbial growth and lets a single vial be used over multiple weeks. Sterile water has no preservative and should generally be reserved for single-use preparations only.
More on Bioglutide (NA-931)
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.